TargetMol

ZM241385

Product Code:
 
TAR-T7021
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7021-1mL1 mL * 10 mM (in DMSO)£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-5mg5mg£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-10mg10mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-25mg25mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-50mg50mg£267.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-100mg100mg£436.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-200mg200mg£622.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7021-500mg500mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
ZM-241385 is a high-affinity antagonist ligand selective for the adenosine A2A receptor.
CAS:
139180-30-6
Formula:
C16H15N7O2
Molecular Weight:
337.343
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9906
SMILES:
Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1
Target:
Adenosine Receptor

References

Wang Z, et al. PLoS One. 2010, 5(11):e13883. Luo Y, Xue Y, Lin Q, et al. CD39 pathway inhibits Th1 cell function in tuberculosis. Immunology. 2022 Pedata F, et al. Mediators Inflamm. 2014: 805198. Lasley RD, et al. Am J Physiol Heart Circ Physiol. 2007, 292(1):H426-31. S. M. Poucher, et al. Br J Pharmacol. 1995 Jul; 115(6): 1096?1102.